<?xml version="1.0" encoding="UTF-8"?>
<p>The presence of diffuse coronary thrombosis, unresponsive to the pharmacologic and mechanical percutaneous therapies, may represent a peculiar expression of the systemic prothrombotic status, which has been described in the clinical scenario of others critically ill patients. Further evidence is needed to determine if the therapeutic research may focus on antiinflammatory mediators or conversely on effective anticoagulation which may prevent cardiovascular injury. It is likely that these two factors should be both addressed by a combination of new therapies.</p>
